நேரம் குழுவினர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from நேரம் குழுவினர். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In நேரம் குழுவினர் Today - Breaking & Trending Today

Lannett Announces FDA Acceptance, As A Priority Original ANDA, Of The Generic Advair Diskus® Filing


Lannett Announces FDA Acceptance, As A Priority Original ANDA, Of The Generic Advair Diskus® Filing
News provided by
Share this article
Share this article
PHILADELPHIA, June 1, 2021 /PRNewswire/  Lannett Company, Inc. (NYSE: LCI) today announced the U.S. Food and Drug Administration (FDA) has accepted the Abbreviated New Drug Application (ANDA) for Fluticasone Propionate and Salmeterol inhalation powder (100/50 mcg, 250/50 mcg and 500/50 mcg), which was submitted by Lannett on behalf of its strategic alliance partner, Respirent Pharmaceuticals Co. Ltd. The FDA assigned a Generic Drug User Fee Act of 2017 (GDUFA II) goal date for this priority original ANDA of January 31, 2022.
The product is the generic equivalent of ADVAIR DISKUS ....

United States , Robert Jaffe , Advair Diskus , Flovent Diskus , Lannett Company , Drug Administration , Exchange Commission , Respirent Pharmaceuticals Co , Lannett Company Inc , Robert Jaffe Co , Abbreviated New Drug Application , Fluticasone Propionate , Respirent Pharmaceuticals , Generic Drug User Fee Act , Tim Crew , Fluticasone Propionate Powder Inhaler , Affordable Respiratory , ஒன்றுபட்டது மாநிலங்களில் , ராபர்ட் ஜாஃப் , லானெட் நிறுவனம் , பரிமாற்றம் தரகு , லானெட் நிறுவனம் இன்க் , ராபர்ட் ஜாஃப் இணை , ஜெநெரிக் மருந்து பயனர் கட்டணம் நாடகம் , நேரம் குழுவினர் ,